Related Experiment Videos
The treatment gap in epilepsy: the current situation and ways forward
H Meinardi1, R A Scott, R Reis
1Department of Physiology, Leyden University Medical Centre, P.O. Box 9604, 2300 RC Leiden, The Netherlands. meinardi@wxs.nl
Epilepsia
|February 24, 2001
Summary
The epilepsy treatment gap affects many in developing nations due to complex factors. Recent interventions show promise in improving access to epilepsy care in underresourced regions.
Area of Science:
- Neurology
- Global Health
- Public Health
Background:
- The International League Against Epilepsy (ILAE) convened a workshop to address the significant epilepsy treatment gap in developing countries.
- This gap represents individuals with epilepsy not receiving adequate medical care, influenced by multifaceted medical, political, social, economic, and cultural determinants.
- The article reviews the current status and underlying causes of the epilepsy treatment gap across diverse global regions.
Framework:
- The workshop focused on identifying barriers and facilitators to epilepsy treatment in resource-limited settings.
- It explored strategies for improving diagnosis, treatment accessibility, and patient adherence to medication.
- A key aspect was understanding the interplay of systemic and individual-level factors contributing to the treatment gap.
Implementation:
- Several recent projects and targeted interventions have demonstrated success in delivering appropriate epilepsy management to underserved populations.
- These initiatives highlight the feasibility of providing effective care even in resource-constrained environments.
- Case studies and program evaluations were discussed to identify best practices.
Implications:
- Successful interventions offer models that may be adapted and scaled to other regions facing similar challenges.
- The findings support the ILAE/International Bureau for Epilepsy/World Health Organization (WHO) Global Campaign against Epilepsy.
- Increased global support and collaborative efforts are crucial for effectively bridging the epilepsy treatment gap worldwide.